NYU Langone Hospital — Long Island is a hospital in Mineola, New York that is the Long Island hospital base of NYU Langone Health System. It was previously known as Nassau Hospital and later Winthrop-University Hospital.

There are 591 beds in Winthrop University Hospital, Clinical Trials Center.

During the past decade, Winthrop University Hospital, Clinical Trials Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 13 clinical trials were completed, i.e. on average, 162.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Winthrop University Hospital, Clinical Trials Center" #1 sponsor was "Pfizer" with 4 trials, followed by "Shire" with 2 trials sponsored, "Actelion" with 1 trials sponsored, "Bellerophon Pulse Technologies" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Winthrop University Hospital, Clinical Trials Center" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Mylan GmbH" with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Winthrop University Hospital, Clinical Trials Center" are "Pulmonary Arterial Hypertension" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Bronchiectasis" (1 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Winthrop University Hospital, Clinical Trials Center" in a lesser frequency.

Most popular intervention types in "Winthrop University Hospital, Clinical Trials Center" are "Drug" (11 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Naproxen" (2 trials), "ADL5859" (1 trials), "AZLI" (1 trials) and "Alemtuzumab 12 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Winthrop University Hospital, Clinical Trials Center" are 14 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Winthrop University Hospital, Clinical Trials Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Winthrop University Hospital, Clinical Trials Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Winthrop University Hospital, Clinical Trials Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".